|
|
|
|
||
Re: going forwardI googled nexavar revenues which as I recall was $800 million annually so that is a better measuring stick than current revenue for dcth imo. I think dcth is attractive except for spending level. I hope, I repeat hope that bod changes have meat instead of fluff. sam |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
56143 | Re: going forward | stillsam | 0 | 1/13/2015 10:33:23 AM |